ETANERCEPT RETENTION RATES IN PATIENTS WITH RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS OR PSORIATIC ARTHRITIS

被引：1
|
作者：
Dongen, C. V. [1 ]
Kneepkens, E. [1 ]
Vogelzang, E. [1 ]
l'Ami, M. [1 ]
Krieckaert, C. [1 ]
van der Horst, I. [1 ,2 ]
Voskuyl, A. [2 ]
Nurmohamed, M. [1 ,3 ]
机构：
[1] Reade, Res & Educ, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Rheumatol, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam Med Ctr, Internal Med, Amsterdam, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.5199
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1043
引用
收藏
页码：1145 / 1145
页数：1
相关论文
共 50 条
  • [21] The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
    Furst, Daniel E.
    Kay, Jonathan
    Wasko, Mary Chester
    Keystone, Edward
    Kavanaugh, Arthur
    Deodhar, Atul
    Murphy, Frederick T.
    Magnus, Jeanette H.
    Hsia, Elizabeth C.
    Hsu, Benjamin
    Xu, Stephen
    Rahman, Mahboob U.
    Doyle, Mittie K.
    [J]. RHEUMATOLOGY, 2013, 52 (10) : 1845 - 1855
  • [22] EFFECT OF TOFACITINIB ON REDUCING PAIN IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Ogdie, A.
    de Vlam, K.
    McInnes, I. B.
    Mease, P. J.
    Baer, P.
    Lukic, T.
    Kwok, K.
    Wang, C.
    Hsu, M. -A.
    Maniccia, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 971 - 972
  • [23] DURATION OF SYMPTOMS BEFORE DIAGNOSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Sorensen, J.
    Hetland, M. L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 80 - 81
  • [24] Effect of Tofacitinib on Reducing Pain in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
    Ogdie, Alexis
    de Vlam, Kurt
    McInnes, Iain B.
    Mease, Philip J.
    Baer, Philip
    Lukic, Tatjana
    Kwok, Kenneth
    Wang, Cunshan
    Hsu, Ming-Ann
    Maniccia, Anna
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [25] Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
    Rossini, M.
    Viapiana, O.
    Orsolini, G.
    Fracassi, E.
    Idolazzi, L.
    Gatti, D.
    Adami, S.
    Govoni, M.
    [J]. REUMATISMO, 2014, 66 (04) : 285 - 303
  • [26] Quantification of radiological damage in inflammatory arthritis: rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
    van der Heijde, D
    [J]. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2004, 18 (06): : 847 - 860
  • [27] Duration Of Symptoms Before Diagnosis In Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis.
    Hetland, Merete Lund
    Sorensen, Jan
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S42 - S43
  • [28] Immunogenicity of golimumab and its clinical relevance in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
    Leu, Jocelyn H.
    Adedokun, Omoniyi J.
    Gargano, Cynthia
    Hsia, Elizabeth C.
    Xu, Zhenhua
    Shankar, Gopi
    [J]. RHEUMATOLOGY, 2019, 58 (03) : 441 - 446
  • [29] Weight Change before and after Diagnosis in Patients with Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis
    Ogdie, Alexis
    George, Michael D.
    Gelfand, Joel
    Dubreuil, Maureen
    Love, Thorvardur
    Baker, Joshua
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [30] GOLIMUMAB UTILIZATION PATTERNS AND REFILL ADHERENCE IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Ellis, L.
    Bolge, S.
    Rice, P.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A49 - A50
12345